Despite of studies on tumor-related antigens, inflammation has been reported to assist in cancer initiation and progression for years [27], and the prognostic significance of systemic inflammatory immunity markers, such as NLR, PLR, MLR [29], fibrinogen [30], D-dimer and albumin [21] has been of paramount interest. Here, ALB is linked to cancer.